Advisor Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$251K Buy
222
+131
+144% +$142K ﹤0.01% 2206
2019
Q3
$108K Sell
91
-18
-17% -$27.5K ﹤0.01% 2831
2019
Q2
$180K Buy
109
+22
+25% +$38.1K ﹤0.01% 2392
2019
Q1
$177K Sell
87
-10
-10% -$17.6K ﹤0.01% 2379
2018
Q4
$124K Buy
97
+13
+15% +$19.9K ﹤0.01% 2462
2018
Q3
$158K Sell
84
-140
-63% -$289K ﹤0.01% 2367
2018
Q2
$455K Sell
224
-1
-0.4% -$2.28K 0.01% 1375
2018
Q1
$499K Buy
225
+4
+2% +$10.2K 0.01% 1330
2017
Q4
$510K Buy
221
+8
+4% +$16.2K 0.01% 1317
2017
Q3
$378K Buy
213
+185
+661% +$258K 0.01% 1375
2017
Q2
$39K Buy
28
+12
+75% +$14.5K ﹤0.01% 3006
2017
Q1
$18K Buy
16
+8
+100% +$8.16K ﹤0.01% 3421
2016
Q4
$6K Sell
8
-207
-96% -$164K ﹤0.01% 3830
2016
Q3
$188K Buy
215
+178
+481% +$129K ﹤0.01% 1553
2016
Q2
$19K Buy
+37
New +$21K ﹤0.01% 3088

Other funds holding BLUE

Advisor Group's BLUE Position: Q4 2019 in Review

Advisor Group increased its bluebird bio (BLUE) stake by 144% in Q4 2019, buying an estimated $142K and bringing the position to 222 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #2206.

Advisor Group first reported a position in BLUE in Q2 2016 and has held it in 15 quarters since. The position peaked at $510K in Q4 2017. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.

  • Advisor Group held 222 shares of bluebird bio worth $251K as of Q4 2019.
  • Advisor Group bought 131 bluebird bio shares in Q4 2019, an estimated $142K.
  • bluebird bio made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2206 holding.
  • Advisor Group first reported a position in bluebird bio in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's bluebird bio position peaked at $510K in Q4 2017.
  • 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.